Has genetics eradicated the good old predictors of hepatitis C treatment response?-Reference-Cited by-同舟云学术

Has genetics eradicated the good old predictors of hepatitis C treatment response?

Published:2011-03 Issue:3 Volume:35 Page:157-158
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Pawlotsky J.-M.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference13 articles.

1. Hepatitis C virus resistance to antiviral therapy;Pawlotsky;Hepatology,2000

2. Is an “a la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?;Poynard;Hepatology,2000

3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol; in press.

4. The results of Phase III clinical trials with telaprevir and boceprevir presented at The Liver Meeting 2010: A new standard of care for hepatitis C virus genotype 1 infection, but with issues still pending;Pawlotsky;Gastroenterology,2011

5. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance;Ge;Nature,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PNPLA3 and IL 28B signature for predicting susceptibility to chronic hepatitis C infection and fibrosis progression;Archives of Physiology and Biochemistry;2019-12-03

2. IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury;The Journal of Infection in Developing Countries;2019-05-31

3. Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis;Hepatology;2013-09-30